Along with our highly trained Radiation Oncologists, Health First Cancer Services utilizes the most advanced radiation technology available including:
Varian TrueBeam™ System - Health First Cancer Services was the first in Florida to offer the TrueBeam™ in August of 2010. The Varian TrueBeam™ is a non-invasive cancer treatment that delivers radiation treatment with pinpoint accuracy and precision. It is one of the most advanced radiotherapy technologies in the world, all while keeping the patient experience in mind with most treatments taking just a few minutes. TrueBeam™ is used for all forms of advanced external beam techniques including image-guided radiotheraphy (IGRT), intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS), and RapidArc® radiotherapy technology.
RapidArc® - RapidArc® is a radiotherapy technology that is among the most advanced forms of intensity modulated radiation therapy (IMRT). The RapidArc® system guides the radiation beam to the tumor in one or two rotations of the machine around the patient. During treatment, the radiation beam is shaped and reshaped as it continuously delivers beams at virtually every angle in a 360-degree revolution. In short, it allows us to deliver a high dose of radiation to kill or sterilize cancer cells in an extremely precise, targeted manner, which spares healthy tissues from damage. Even the most complicated targets can complete treatments in 15 minutes or less.
Intensity-Modulated Radiation Therapy (IMRT) - is a computer-based form of radiotherapy that allows radiation oncologists to send external beams in the 3-D shape of tumors in small multiple doses with precision. Because the tumor can be contoured more efficiently with IMRT, the radiation doses to healthy surrounding tissues are minimized, thus patients treated with IMRT experience fewer harsh side effects from radiation therapy.
Image-Guided Radiation Therapy (IGRT) - provides high-resolution, 3-D images to pinpoint tumor sites, adjust patient positioning when necessary, and complete a treatment. Patients are x-rayed before each treatment. Those x-rays are compared to the patient's initial CT scan and the patient is matched perfectly to their original set-up position - every single treatment. This positioning system is far superior to skin marks or tattoos that are placed on the patient's skin. IGRT can also account for daily organ movement and changes in the patient's internal anatomy throughout the course of their treatment.
Stereotactic Radiosurgery (SRS) - is a form of radiation therapy that focuses high-powered radiation beams and the use of a special non-invasive head frame. Stereotactic radiosurgery better targets the abnormal cancerous area in a single fraction. Because the treatment is delivered using strategically placed dynamic conformal arcs, the dose to the normal tissues surrounding the target is significantly reduced.
Stereotactic Body Radiotherapy (SBRT) - is typically used to treat small, early-stage tumors of the lung or isolated recurrences or metastases from various types of cancer. Treatment is painless and usually over 2 to 5 fractions and generally completed in one week. Advantages over conventional radiotherapy include the ability to irradiate smaller normal tissue volume because of the more rapid dose fall-off. As a result, side effects are rare and most treatments are completed in 20 minutes or less.
Internal Radiation Therapy (Brachytherapy) - treats cancer by placing radioactive sources directly into or next to the area requiring treatment. This allows for the delivery of a high dose of radiation with minimal impact on surrounding healthy tissues. It has been proven to be highly successful in treating prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck cancers.
Radiopharmaceuticals such as Xofigo, Samarium, and I-131 - these are a form of liquid radiation that is either taken orally or injected intravenously to treat specific benign and malignant conditions. I-131 is taken orally to treat benign thyroid conditions and in higher doses, certain types of thyroid cancers. Xiofigo is administered intravenously for the treatment of prostate cancer after it has spread to the bones. Samarium (SM-153) is a type of injectable radiation treatment that helps reduce pain in patients whose cancer has spread to the bones. The radioactive material in the samarium treatment only goes into the cancer cells and not into the healthy bones or tissue.